Results of the February 2020 Movember Prostate Cancer Translation Acceleration Grant in Advanced Imaging
We are pleased to announce the results of the most recent Translation Acceleration Grants competition. With this funding opportunity, members of the prostate cancer research community were asked to collaboratively participate in a multi-stage process to submit one or more application(s) for an investigator-initiated Translation Acceleration Grant (TAG). New imaging modalities are increasing our ability to detect low volume prostate cancer metastases. The project funded by this mechanism will explore how advanced imaging such as PET, CT and mpMRI, together with appropriate treatment for men with advanced prostate cancer can lead to better outcomes. Below is a listing of the newly awarded Movember Translation Acceleration Grant.
Funding for this competition has been provided by Movember. This project totals almost $3 million in funding over the full term of the grant.
PC-TAG20 - Abstract
- Amounts listed below represent the total dollars awarded by grant year and may include funds for salaries, supplies, and/or equipment.
- The start date for this grant is July 1, 2020.
- Only the Principal Investigator is named in this listing. Co-Principal Investigators, Co-Applicants and/or Additional Authors may also be associated with this grant.
Although every effort has been made to ensure the accuracy of the listing below, this list does not constitute an "official" notification.
Successful applicants will be informed, in writing, with an official Notification of Award giving the details pertaining to their grant.
Centre de recherche du CHUM
PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer (PATRON): A Pragmatic Phase III Randomized Controlled Trial
2022/2023 : $812,977
2023/2024 : $153,782
2024/2025 : $215,653
2025/2026 : $122,728
Last modified on: September 29, 2020